Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2000-11-14 (25 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: GUER (56380), Morbihan
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE L'ESPLANADE : revenue, balance sheet and financial ratios
PHARMACIE DE L'ESPLANADE is a French company
founded 25 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in GUER (56380),
this company of category PME
shows in 2024 a net income positive of 367 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE L'ESPLANADE (SIREN 433994753)
Indicator
2024
2023
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
Net income
367 481 €
388 842 €
349 565 €
242 275 €
200 172 €
EBITDA
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DE L'ESPLANADE generates positive net income of 367 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 200 k€ -> 367 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
367 481 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 5%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 82%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
4.561%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
81.671%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE L'ESPLANADE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2023
2024
Debt ratio
15.955
38.885
25.728
6.071
4.561
Financial autonomy
77.828
63.608
69.406
81.395
81.671
Repayment capacity
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
4.562024
2019
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Excellent
In 2024, the debt ratio of PHARMACIE DE L'ESPLANADE (4.56) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
81.67%2024
2019
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent+8 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DE L'ESPLANADE (81.7%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 184.77. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
184.772
Liquidity indicators evolution PHARMACIE DE L'ESPLANADE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2023
2024
Liquidity ratio
230.748
211.889
186.51
171.838
184.772
Interest coverage
None
None
None
None
None
Sector positioning
Liquidity ratio
184.772024
2019
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Good-6 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DE L'ESPLANADE (184.77) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE DE L'ESPLANADE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DE L'ESPLANADE is estimated at
5 130 306 €
(range 3 572 664€ - 7 675 231€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
3572k€5130k€7675k€
5 130 306 €Range: 3 572 664€ - 7 675 231€
NAF 5 année 2024
Valuation method used
Net Income Multiple
367 481 €
×
14.0x
=5 130 306 €
Range: 3 572 664€ - 7 675 232€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE L'ESPLANADE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE L'ESPLANADE
What is the revenue of PHARMACIE DE L'ESPLANADE ?
The revenue of PHARMACIE DE L'ESPLANADE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE L'ESPLANADE profitable?
Yes, PHARMACIE DE L'ESPLANADE generated a net profit of 367 k€ in 2024.
Where is the headquarters of PHARMACIE DE L'ESPLANADE ?
The headquarters of PHARMACIE DE L'ESPLANADE is located in GUER (56380), in the department Morbihan.
Where to find the tax return of PHARMACIE DE L'ESPLANADE ?
The tax return of PHARMACIE DE L'ESPLANADE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE L'ESPLANADE operate?
PHARMACIE DE L'ESPLANADE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart